Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
Open Access
- 1 November 2020
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 4749-4763
Abstract
Purpose: Homoharringtonine (HHT) has been used as an antileukemia agent in the clinic which processes a high-potential therapeutic efficacy against multiple myeloma (MM). In this study, we investigated the antimyeloma mechanism of HHT. Methods: Three MM cell lines and a xenograft model were applied. Mitochondrial function was evaluated by detecting MitoTracker Green, the mtDNA copy number, mitochondrial protein and enzyme activity, the mitochondrial membrane potential and mitochondrial morphology. Mitophagy levels were assessed by monitoring autophagosomes, performing a colocalization analysis and determining the levels of related proteins. An shRNA was applied to knockdown Parkin. Results: Based on the results of the in vitro experiments, HHT exerted a promising antiproliferative effect on the MM.1S, RPMI 8226 and H929 cell lines by increasing mitophagy. In addition, HHT markedly inhibited myeloma tumor growth and prolonged survival by promoting mitophagy in vivo. Furthermore, HHT treatment contributed to notable mitochondrial dysfunction and Parkin-dependent mitophagy, as evidenced by the destruction of mitochondria, the decrease in the mtDNA copy number, decrease in the Bcl-2/Bax ratio, and decrease in the levels of mitochondrial proteins and the optimal expression of Parkin and NDP52. However, the addition of rapamycin did not produce significant synergistic effect with HHT, indicating that HHT reached the threshold level to induce mitophagy. The colocalization analysis and assessment of mitochondrial function examination further confirmed that HHT triggered mitophagy and mitochondrial dysfunction. Moreover, the antiproliferative effect of HHT was reversed by an shRNA targeting Parkin, highlighting the indispensable role of Parkin-dependent mitophagy in the antimyeloma effect of HHT. Conclusion: HHT exerts an antimyeloma effect by inducing excess mitophagy, providing new mechanistic insights into a therapeutic strategy for MM.Keywords
This publication has 41 references indexed in Scilit:
- Homoharringtonine and omacetaxine for myeloid hematological malignanciesJournal of Hematology & Oncology, 2014
- Energy transfer in "parasitic" cancer metabolismCell Cycle, 2011
- Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling HistochemistryJournal of Visualized Experiments, 2011
- Targeting Mitochondrial Dysfunction: Role for PINK1 and Parkin in Mitochondrial Quality ControlAntioxidants & Redox Signaling, 2011
- Mechanisms of mitophagyNature Reviews Molecular Cell Biology, 2010
- Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysemaProceedings of the National Academy of Sciences of the United States of America, 2010
- Chapter 1 Monitoring Autophagy in Mammalian Cultured Cells through the Dynamics of LC32009
- Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-cateninInternational Journal of Hematology, 2008
- Homoharringtonine inhibits the AKT pathway and inducesin vitroandin vivocytotoxicity in human multiple myeloma cellsLeukemia & Lymphoma, 2008
- Homoharringtonine induces apoptosis and growth arrest in human myeloma cellsLeukemia & Lymphoma, 2007